BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Bio NC

  Conversion Right Triggered For Laboratory Corporation of America Holdings (LabCorp)’s Zero Coupon Convertible Subordinated Notes Due 2021

  July 1, 2014

   · 

  1 min read
• Genetown

  Advanced Cell Technology Announces Paul K. Wotton Ph.D. Recognized As Ernst & Young LLP 2014 Entrepreneur Of The Year™ For New Jersey Region

  July 1, 2014

   · 

  1 min read
• Lone Star Bio

  Novel Kinetic Concepts, Inc. Skin Graft Harvesting Tool Now Available In Europe

  July 1, 2014

   · 

  1 min read
• Pharm Country

  Ipsen Submits Marketing Authorization Applications In The U.S. And Europe For Somatuline® (Lanreotide) In The Treatment Of Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets)

  July 1, 2014

   · 

  1 min read
• Drug Development

  Genocea Biosciences Announces Positive Top-Line 12-Month Follow-Up Data From Phase 1/2a Clinical Trial For HSV-2 Immunotherapy GEN-003

  July 1, 2014

   · 

  1 min read
• Cyber Kiosk Solutions Receives Its First Shipment Of Branded Saliva Drug Tests And Places Units For Sale In Florida

  July 1, 2014

   · 

  3 min read
• Drug Development

  Specialty Vaccine Company PaxVax, Inc. Announces Positive Efficacy Results For Phase 3 Cholera Challenge Study

  July 1, 2014

   · 

  1 min read
• Deals

  ANI Pharmaceuticals, Inc. Buys Lithobid Extended Release Tablets From Noven Therapeutics For $12 Million

  July 1, 2014

   · 

  4 min read
• Business

  CompaniondDx Reference Lab, LLC And Regenwell Holdings, LLC Partner To Provide World-Class Care To Patients

  July 1, 2014

   · 

  1 min read
• Drug Development

  Threshold Pharmaceuticals, Inc. Initiates 440-Patient, Randomized, Double-Blind, Placebo-Controlled Trial Of TH-302 In Combination With Pemetrexed In Advanced Non-Squamous Non-Small Cell Lung Cancer

  July 1, 2014

   · 

  7 min read